HIV Drugs Market
HIV Drugs Market - Global Industry Assessment & Forecast
#
Pages:
143
Base Year:
2022
Mar - 2023
Format:
Report Code:
VMR-2036
Segments Covered
By
Drug Classes Integrase Inhibitors, Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Combination HIV Medicines, Other Drug Classes
-
By
Distribution Channels Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 31.3 Billlion |
 Revenue 2030:
|
USD 40.3 Billlion |
 Revenue CAGR
(2023 - 2030): |
3.7% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
HIV Drugs Market Segment Analysis
- HIV Drugs Drug Classes Outlook (Revenue, USD Million, 2018 - 2030)
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
- HIV Drugs Distribution Channels Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
-
North America HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- U.S.
- U.S. HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
- U.S. HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- U.S. HIV Drugs Market, by Drug Classes
- Canada
- Canada HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
- Canada HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Canada HIV Drugs Market, by Drug Classes
-
Mexico
- Mexico HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
- Mexico HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Mexico HIV Drugs Market, by Drug Classes
-
North America HIV Drugs Market, by Drug Classes
- Europe
-
Europe HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
-
Europe HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- U. K.
- U.K. HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
- U.K. HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- U.K. HIV Drugs Market, by Drug Classes
- France
- France HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
- France HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- France HIV Drugs Market, by Drug Classes
-
Germany
- Germany HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
- Germany HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Germany HIV Drugs Market, by Drug Classes
-
Italy
- Italy HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
- Italy HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Italy HIV Drugs Market, by Drug Classes
-
Spain
- Spain HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
- Spain HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Spain HIV Drugs Market, by Drug Classes
-
Rest of Europe
- Rest of Europe HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
- Rest of Europe HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Rest of Europe HIV Drugs Market, by Drug Classes
-
Europe HIV Drugs Market, by Drug Classes
- Asia Pacific
-
Asia Pacific HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
-
Asia Pacific HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- China
- China HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
- China HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- China HIV Drugs Market, by Drug Classes
- Japan
- Japan HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
- Japan HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Japan HIV Drugs Market, by Drug Classes
-
Germany
- Germany HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
- Germany HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Germany HIV Drugs Market, by Drug Classes
-
India
- India HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
- India HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- India HIV Drugs Market, by Drug Classes
-
South Korea
- South Korea HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
- South Korea HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- South Korea HIV Drugs Market, by Drug Classes
-
South East Asia
- South East Asia HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
- South East Asia HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- South East Asia HIV Drugs Market, by Drug Classes
-
Rest of Asia Pacific
- Rest of Asia Pacific HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
- Rest of Asia Pacific HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Rest of Asia Pacific HIV Drugs Market, by Drug Classes
-
Asia Pacific HIV Drugs Market, by Drug Classes
- Latin America
-
Latin America HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
-
Latin America HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Brazil
- Brazil HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
- Brazil HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Brazil HIV Drugs Market, by Drug Classes
- Argentina
- Argentina HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
- Argentina HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Argentina HIV Drugs Market, by Drug Classes
-
Rest of Latin America
- Rest of Latin America HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
- Rest of Latin America HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Rest of Latin America HIV Drugs Market, by Drug Classes
-
Latin America HIV Drugs Market, by Drug Classes
- Middle East & Africa
-
Middle East & Africa HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
-
Middle East & Africa HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- GCC Countries
- GCC Countries HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
- GCC Countries HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- GCC Countries HIV Drugs Market, by Drug Classes
- South Africa
- South Africa HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
- South Africa HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- South Africa HIV Drugs Market, by Drug Classes
-
Rest of Middle East & Africa
- Rest of Middle East & Africa HIV Drugs Market, by Drug Classes
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Other Drug Classes
- Rest of Middle East & Africa HIV Drugs Market, by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Rest of Middle East & Africa HIV Drugs Market, by Drug Classes
-
Middle East & Africa HIV Drugs Market, by Drug Classes
- North America
Vantage Market
Research | 23-Mar-2023
FAQ
Frequently Asked Question
What is the global demand for HIV Drugs in terms of revenue?
-
The global HIV Drugs valued at USD 31.3 Billlion in 2022 and is expected to reach USD 40.3 Billlion in 2030 growing at a CAGR of 3.7%.
Which are the prominent players in the market?
-
The prominent players in the market are ViiV Healthcare (U.S.), Gilead Sciences Inc. (U.S.), Glaxo Smith Kline PLC (U.K.), Merck Sharp & Dohme Corp. (France), Bristol-Myers Squibb Company (U.S.), Janssen Pharmaceuticals Inc. (Johnson & Johnson) (Belgium), Boehringer Ingelheim International GmbH (Germany), AbbVie Inc. (U.S.), Genentech Inc. (F. Hoffmann-La Roche AG) (U.S.), Mylan N.V. (U.S.).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 3.7% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the HIV Drugs include
- Increase in number of HIV infected patients worldwide
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the HIV Drugs in 2022.
